A recent article in the Washington Post ("Gilead AIDS Drug Shows Prevention Promise") heralds promising new scientific results that use of an anti-retroviral drug among healthy people may prevent transmission of HIV/AIDS. Trials in monkeys showed complete protection despite repeated exposure to HIV over the course of more than three months, and according to the article "if larger tests show the drugs work, they could be given to people at highest risk of HIVâ€”from gay men in American cities to women in Africa who catch the virus from their partners."
CGD Policy Blogs
After a bitter fight between the World Bank's board of directors and Bank President Paul Wolfowitz, Congo-Brazzaville was allowed to reach decision point in the HIPC program on March 9. The deal was almost held up after reports that Congo’s President Denis Sassou-Ngueso spent $300k at a New York hotel, but this scandal wasn’t enough to convince debt relief diehards that Congo wasn’t perhaps the most worthy recipien
In January, representatives from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Bank AIDS program, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) met in Washington to discuss ways of improving coordination between their programs.
The U.S. Agency for International Development just released its initial estimates of how much foreign aid the U.S. government gave to developing countries in 2005. It submitted the figures as part of normal reporting processes to the Paris-based Development Assistance Committee. The overall figure is a stunner: U.S.
The New York Times today describes the progress being made in the defeat of Guinea worm.
Now, thanks to a relentless 20-year campaign led by former President Jimmy Carter, Guinea worm is poised to become the first disease since smallpox to be pushed into oblivion. Fewer than 12,000 cases were found last year, down from 3 million in 1986.
Today's Economist has an article about Advance Market Commitments which describes criticisms of the idea by Oxford economist, Andrew Farlow. (The full text of the Economist article is below).
The article mentions three of Dr Farlow's concerns:
- that the terms might create an incentive for less effective vaccines
- that drugs companies might use bribes to increase their share of the valuable market
- that the promise of future purchases might not be credible
As if 782 percent inflation, mass homelessness caused by their own government, and an economy worse than a warzone weren't enough for the beleaguered Zimbabwean people, they now face this: No more Coca-Cola. The BBC is reporting that local bottlers can no longer get foreign exchange to import the syrup, so Coke fans (probably most Zimbabweans) must go without their favorite drink for now.